Log in to save to my catalogue

Cardioprotection with halogenated gases: how does it occur?

Cardioprotection with halogenated gases: how does it occur?

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4a179f1884144fbba15fd5de2da7aca6

Cardioprotection with halogenated gases: how does it occur?

About this item

Full title

Cardioprotection with halogenated gases: how does it occur?

Publisher

New Zealand: Dove Medical Press Limited

Journal title

Drug design, development and therapy, 2017-01, Vol.11, p.837-849

Language

English

Formats

Publication information

Publisher

New Zealand: Dove Medical Press Limited

More information

Scope and Contents

Contents

Numerous studies have studied the effect of halogenated agents on the myocardium, highlighting the beneficial cardiac effect of the pharmacological mechanism (preconditioning and postconditioning) when employed before and after ischemia in patients with ischemic heart disease. Anesthetic preconditioning is related to the dose-dependent signal, whil...

Alternative Titles

Full title

Cardioprotection with halogenated gases: how does it occur?

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_4a179f1884144fbba15fd5de2da7aca6

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4a179f1884144fbba15fd5de2da7aca6

Other Identifiers

ISSN

1177-8881

E-ISSN

1177-8881

DOI

10.2147/DDDT.S127916

How to access this item